Inventor · disambiguated record
Bryan Oates
Also filed as: OATES BRYAN · OATES BRYAN DOUGLAS
11 granted patents·1 pending application·199 citations·filing 1998–2012
91Inventor score
Top patents by PatentIndex Score
12 records- 0191US6432981B1Cyclopentyl modulators of chemokine receptor activityMERCK & CO INC·Filed 2000·Granted Aug 13, 2002·36 cites·27 claims
- 0289US6140349ACyclic amine modulators of chemokine receptor activityMERCK & CO INC·Filed 1999·Granted Oct 31, 2000·44 cites·32 claims
- 0389US6136827ACyclic amine modulations of chemokine receptor activityMERCK & CO INC·Filed 1998·Granted Oct 24, 2000·52 cites·20 claims
- 0488US6538002B1Cyclopentyl modulators of chemokine receptor activityMERCK & CO INC·Filed 2000·Granted Mar 25, 2003·22 cites·20 claims
- 0582US6500844B1Cyclopentyl modulators of chemokine receptor activityMERCK & CO INC·Filed 2000·Granted Dec 31, 2002·13 cites·20 claims
- 0681US6476054B1Cyclic amine modulators of chemokine receptor activityMERCK & CO INC·Filed 2000·Granted Nov 5, 2002·10 cites·27 claims
- 0781US6358979B1N-cyclopentyl modulators of chemokine receptor activityMERCK & CO INC·Filed 2000·Granted Mar 19, 2002·12 cites·39 claims
- 0872US8293714B2Anti-angiogenic compoundsDOPPALAPUDI VENKATA RAMANA·Filed 2009·Granted Oct 23, 2012·2 cites·33 claims
- 0968US6472410B1N-cyclopentyl modulators of chemokine receptor activityMERCK & CO INC·Filed 2000·Granted Oct 29, 2002·4 cites·31 claims
- 1066US6593346B2N-cyclopentyl modulators of chemokine receptor activityMERCK & CO INC·Filed 2002·Granted Jul 15, 2003·3 cites·27 claims
- 1165US8937048B2Anti-angiogenic compoundsDOPPALAPUDI VENKATA RAMANA·Filed 2012·Granted Jan 20, 2015·1 cites·22 claims
- 1246US2009098130A1Glucagon-like protein-1 receptor (glp-1r) agonist compoundsBRADSHAW CURT W·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bryan Oates files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →